News

Alarar Capital Group Securities Adds Underwriting License, Strengthening Global Capital Markets Platform
Alarar Capital Group Appointed as Exclusive Financial Advisor to XRP Healthcare M&A Holding Inc. on Definitive Agreement for Proposed Qualifying Transaction with AAJ Capital 3 Corp.
Alarar Capital Group Joins Celebration of the Best Workplaces™ in Hong Kong 2025
Alarar Capital Group Honoured as One of the Best Workplaces™ in Hong Kong 2025
Alarar Capital Group Advises Empro Group Inc. on Initial Public Offering on Nasdaq Capital Market
Alarar Capital Group Celebrates New Chapter with Opening of Hong Kong Office
Capital Markets High Tea 2025: Navigating U.S. Listings and De-SPAC Strategies in Vietnam
Meey Group Selects Alarar Capital Group as Exclusive Financial Advisor for Planned U.S. IPO
Alarar Capital Group Earns Accreditation as a Great Place To Work-Certified™ Company!
XRP Healthcare Enters LOI for Qualifying Transaction with AAJ Capital 3 Corp., Alarar Capital Group Appointed as Exclusive Advisor
Alarar Capital Group Advises Cyclacel Pharmaceuticals on Proposed Share Exchange with fitters Sdn. Bhd.
D. Boral Capital and Alarar Capital Group Launch Series of SPACs
Sayward Capital Corp. and Technosteel Construction (L.L.C.) Enter Definitive Agreement for Business Combination
Capital Markets and M&A Forum 2025: 10th Anniversary Edition – Celebrating a Decade of Growth, Strategy, and Cross-Border Collaboration
Alarar Capital Group Advises BeLive Holdings on Successful Nasdaq IPO
Alarar Capital Group Supports Cyclacel Pharmaceuticals in $1 Million Private Placement of Convertible Preferred Stock
UPDATE: SEC Approves Listing Rule Changes
Alarar Capital Group's Team-Building Getaway: Strengthening Connections and Celebrating Success
Alarar Capital Group Advises on Share Purchase and Change of Control of Cyclacel Pharmaceuticals
Alarar Capital Group Successfully Concludes Capital Markets & M&A Forum Shanghai 2025, Celebrating a Decade of Excellence
Alarar Capital Group Celebrates a Decade of Exellence
Alarar Capital Group Advises Cyclacel Pharmaceuticals on $25M PIPE Financing
D. Boral Capital Secures Strategic Investments from Alarar Capital Group and an Institutional Investor
METAVISIO - THOMSON Computing Signs Engagement Agreement with Alarar Capital Group for U.S. Listing on Nasdaq or NYSE
Update: NASDAQ Proposed Listing Rule Change
Alarar Capital Group Celebrates Strong Finish at 2024 China Cup, Showcasing Commitment to Excellence and Resilience
Alarar Capital Group Proudly Sponsors Team ARC in the 16th China Cup International Regatta 2024
Alarar Capital Group Announces Successful IPO of Gelteq Limited on Nasdaq
Alarar Capital Group Successfully Advises Fresenius Medical Care on Strategic Divestment of Six Hospital Centers in China
Green Economy Forum & Exhibition (GEFE) 2024: “A Vital Platform for Europe-Vietnam Cooperation”
Alarar Capital Group Receives 2024 Frost & Sullivan Company of the Year Award for Excellence in Asian Mid-Market Investment Advisory
Alarar Capital Group Featured in The Smart Investor’s Exclusive September-October 2024 Edition